Takeda Obtains 100% Control of China JV

Takeda Pharma of Japan will acquire the remaining 25% of its China JV, Tianjin Takeda Pharmaceuticals Co., Ltd., from its former partner, Tianjin Lisheng Pharma, giving Takeda complete control of the enterprise. Lishing, a state-owned company, decided last year to sell its 25% stake. By law, Lishing was required to hold an auction, and Takeda was the only bidder, though the amount was not disclosed. More details.... Stock Symbol: (TO: 4502)